Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 6915789, 7 pages
http://dx.doi.org/10.1155/2016/6915789
Research Article

Development of a New Hybrid Biodegradable Drug-Eluting Stent for the Treatment of Peripheral Artery Disease

1Division of Cardiology, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Republic of Korea
2Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
3Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea
4Cardiovascular Product Evaluation Center, Yonsei University College of Medicine, Seoul, Republic of Korea
5Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea

Received 11 September 2016; Accepted 3 November 2016

Academic Editor: Gabriele Piffaretti

Copyright © 2016 Jung-Hee Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Dormandy and R. B. Rutherford, “Management of Peripheral Arterial Disease (PAD). TASC working group. TransAtlantic Inter-Society Consensus (TASC),” Journal of Vascular Surgery, vol. 31, no. 1, part 2, pp. S1–S296, 2000. View at Google Scholar
  2. M. Schillinger, S. Sabeti, C. Loewe et al., “Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery,” The New England Journal of Medicine, vol. 354, no. 18, pp. 1879–1888, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Schillinger, S. Sabeti, P. Dick et al., “Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting,” Circulation, vol. 115, no. 21, pp. 2745–2749, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Dick, H. Wallner, S. Sabeti et al., “Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions,” Catheterization and Cardiovascular Interventions, vol. 74, no. 7, pp. 1090–1095, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Scheinert, S. Scheinert, J. Sax et al., “Prevalence and clinical impact of stent fractures after femoropopliteal stenting,” Journal of the American College of Cardiology, vol. 45, no. 2, pp. 312–315, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Werner, A. Micari, A. Cioppa et al., “Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: the GAIA study,” JACC: Cardiovascular Interventions, vol. 7, no. 3, pp. 305–312, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. C. M. Bünger, N. Grabow, K. Sternberg et al., “A biodegradable stent based on poly(L-lactide) and poly(4-hydroxybutyrate) for peripheral vascular application: preliminary experience in the pig,” Journal of Endovascular Therapy, vol. 14, no. 5, pp. 725–733, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. Institute for Laboratory Animal Resources (US), Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Resources (US), Washington, DC, USA, 1996.
  9. G. S. Mintz, S. E. Nissen, W. D. Anderson et al., “American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on clinical expert consensus documents,” Journal of the American College of Cardiology, vol. 37, no. 5, pp. 1478–1492, 2001. View at Publisher · View at Google Scholar
  10. R. S. Schwartz, K. C. Huber, J. G. Murphy et al., “Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model,” Journal of the American College of Cardiology, vol. 19, no. 2, pp. 267–274, 1992. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Y. Lim, M. H. Jeong, S. J. Hong et al., “Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis,” Circulation Journal, vol. 72, no. 3, pp. 463–468, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. O. European Stroke, M. Tendera, V. Aboyans et al., “ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC),” European Heart Journal, vol. 32, no. 22, pp. 2851–2906, 2011. View at Publisher · View at Google Scholar
  13. O. Schlager, P. Dick, S. Sabeti et al., “Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures,” Journal of Endovascular Therapy, vol. 12, no. 6, pp. 676–684, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Suh, Y.-G. Ko, S. H. Lee, M.-D. Kim, and D. Choi, “Crushed stent with acute occlusion in superficial femoral artery after enhanced external counterpulsation,” JACC: Cardiovascular Interventions, vol. 7, no. 10, pp. e141–e142, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-J. Lee, D.-H. Shin, J.-S. Kim et al., “Femoropopliteal artery stent fracture with recurrent in-stent reocclusion and aneurysm formation: successful treatment with self-expandable Viabahn endoprosthesis,” Korean Circulation Journal, vol. 45, no. 6, pp. 522–525, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Onuma and P. W. Serruys, “Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?” Circulation, vol. 123, no. 7, pp. 779–797, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Ormiston and P. W. S. Serruys, “Bioabsorbable coronary stents,” Circulation: Cardiovascular Interventions, vol. 2, no. 3, pp. 255–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. P. Oberhauser, S. Hossainy, and R. J. Rapoza, “Design principles and performance of bioresorbable polymeric vascular scaffolds,” EuroIntervention, vol. 5, pp. F15–F22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Prabhu and S. Hossainy, “Modeling of degradation and drug release from a biodegradable stent coating,” Journal of Biomedical Materials Research Part A, vol. 80, no. 3, pp. 732–741, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. G. Ellis, D. J. Kereiakes, D. C. Metzger et al., “Everolimus-eluting bioresorbable scaffolds for coronary artery disease,” The New England Journal of Medicine, vol. 373, no. 20, pp. 1905–1915, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Gao, Y. Yang, Y. Han et al., “Bioresorbable vascular scaffolds versus metallic stents in patients with coronary artery disease: ABSORB China Trial,” Journal of the American College of Cardiology, vol. 66, no. 21, pp. 2298–2309, 2015. View at Publisher · View at Google Scholar
  22. P. W. Serruys, B. Chevalier, D. Dudek et al., “A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial,” The Lancet, vol. 385, no. 9962, pp. 43–54, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Kimura, K. Kozuma, K. Tanabe et al., “A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan,” European Heart Journal, vol. 36, no. 47, pp. 3332–3342, 2015. View at Publisher · View at Google Scholar
  24. P. W. Serruys, G. Sianos, A. Abizaid et al., “The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES),” Journal of the American College of Cardiology, vol. 46, no. 2, pp. 253–260, 2005. View at Publisher · View at Google Scholar · View at Scopus